Avid Bioservices Inc (CDMO)

[biopharm]

In another aspect, the surfactant can be an ampholytic surfactant, which possess both positive (cationic) and negative (anionic) charges on the main molecular chains and with their relative counter ions. The cationic part is based on primary, secondary, or tertiary amines or quaternary ammonium cations. The anionic part can be more variable and include sulfonates, as in the sultaines CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate) and cocamidopropyl hydroxysultaine. Betaines such as cocamidopropyl betaine have a carboxylate with the ammonium. Some of the ampholytic surfactants may have a phosphate anion with an amine or ammonium, such as the phospholipids phosphatidylserine, phosphatidylethanolamine, phosphatidylcholine, and sphingomyelins.

Examples of surfactants also include, but are not limited to, dodecyl sulfate sodium salt, sodium lauryl sulfate, dodecyl sulfate ammonium salt, secondary alkane sulfonates, alcohol ethoxylate, acetylenic surfactant, and any combination thereof. Examples of suitable commercially available surfactants include TRITON™, Tergitol™, DOWFAX™ family of surfactants manufactured by Dow Chemicals and various surfactants in SURFYNOL™, DYNOL™, Zetasperse™, Nonidet™, and Tomadol™ surfactant families, manufactured by Air Products and Chemicals. Suitable surfactants of surfactants may also include polymers comprising ethylene oxide (EO) and propylene oxide (PO) groups. An example of EO-PO polymer is Tetronic™ 90R4 from BASF Chemicals.

http://www.freepatentsonline.com/y2018/0002571.html

_____

Wonder why Merck is all so quiet on PS Targeting wearable clothing that sensors will be required to target flipped PS

https://www.emdgroup.com/en/news/versum-definitive-agreement-12-04-2019.html

_____

Let's go PS Targeting ... this is far from over and even Udit Batra is well aware how coy Merck and friends can be

CDMO will certainly be busy and when IIS jump into CDMO as it went from 25% to 60% (just what the public sees) then one must ask is there a chance that we are more like 85% shares held in strong hands, even with John Springs Stafford trying to squeeze every last share out of weak hands

Good luck, I doubt anyone of the dozens of medical equipment out there will be able to monitor for levels of Parkinson's Alzheimer's etc etc etc if they don't infringe upon PS Targeting patents